Soligenix Reports First Quarter 2014 Financial Results, and Highlights Recent Accomplishments

[PR Newswire] – PRINCETON, N.J., May 12, 2014 /PRNewswire/ — Soligenix, Inc. (SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet more

View todays social media effects on XON

View the latest stocks trending across Twitter. Click to view dashboard

See who Intrexon is hiring next, click here to view